Evidence map›Paper›PMID 28534214›Full record

ArticleMolecular imaging and biology2017

Repeatability of [

Joseph R Osborne, Teja M Kalidindi, Blesida J Punzalan, Kishore Gangangari, Daniel E Spratt, Wolfgang A Weber, Steven M Larson, Naga Vara Kishore Pillarsetty

Erratum issuedOpen access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular imaging and biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Dynamic patterns of [European journal of nuclear medicine and molecular imaging · 2020
    Article
  4. Detection Threshold and Reproducibility ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2018
    Article
  5. Prostate cancer and prostatic diseases · 2018
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Joseph R OsborneDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 77, New York, NY, 10065, USA. osbornej@mskcc.org.
Teja M KalidindiMolecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Blesida J PunzalanMolecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Kishore GangangariDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 77, New York, NY, 10065, USA.
Daniel E SprattDepartment of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
Wolfgang A WeberDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 77, New York, NY, 10065, USA.
Steven M LarsonDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 77, New York, NY, 10065, USA.
Naga Vara Kishore PillarsettyDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 77, New York, NY, 10065, USA.
Memorial Sloan Kettering Cancer Center · USCornell University · USHunter College · USUniversity of Michigan–Ann Arbor · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Memorial Sloan Kettering Small Animal Imaging ResearchR24CA083084 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI KOUTCHER, JASON ARTHUR · 1999 to 2006
$4.4M
A new technique to make 68Ga-labeled pharmaceuticals widely available for clinical useR01CA207645 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI EASWARAMOORTHY, BALU, OSBORNE, JOSEPH REGINALD · 2016 to 2018
$1.7M
Immuno-PET With Anti-PSMA 89Zr-J591 mAb For Molecular Imaging of Prostate CancerR21CA153177 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI OSBORNE, JOSEPH REGINALD · 2011 to 2012
$404k
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA207645NCI NIH HHS R21 CA153177NCI NIH HHS R24 CA083084
6 · The paper itself

Abstract

purposeWe studied the effect of varying specific activity of [ PROCEDURES: Athymic nude mice bearing PC3-PIP (PSMA+) and PC3 (PSMA-) bilateral flank tumors were assessed to study intra- and inter-day repeatability of [

resultsRegion of interest (ROI) analysis of the [

conclusionsThis study demonstrates that [

Indexed as

Positron-Emission TomographyAnimalsCell Line, TumorGallium RadioisotopesHumansMaleMiceProstate-Specific AntigenProstatic NeoplasmsRadiopharmaceuticalsReproducibility of ResultsTissue DistributionXenograft Model Antitumor AssaysGallium RadioisotopesProstate-Specific AntigenRadiopharmaceuticalsGallium-68MicePositron emission tomographyProstate cancerPSMARepeatabilitySpecific activity

Identifiers

PMID28534214
PMCPMC5664162
OpenAlexW2617113244

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.